المؤلفون: Jesús Fortún, Elia Gómez-García de la Pedrosa, Alberto Martínez-Lorca, Patricia Paredes, Pilar Martín-Dávila, Alicia Gómez-López, María José Buitrago, Javier López-Jiménez, Francesca Gioia, Rosa Escudero, Maria Elena Alvarez-Alvarez, Cruz Soriano, Javier Moreno-García, Diana San Miguel, Noelia Vicente, Santiago Moreno

المصدر: Journal of Fungi, Vol 10, Iss 3, p 191 (2024)

مصطلحات موضوعية: invasive pulmonary aspergillosis, nebulized liposomal amphotericin B, 18 F-fluorodeoxyglucose positron emission tomography, Biology (General), QH301-705.5

Relation: https://www.mdpi.com/2309-608X/10/3/191; https://doaj.org/toc/2309-608X; https://doaj.org/article/55f00a22f62d40f292788955aec4af09

الاتاحة: https://doi.org/10.3390/jof10030191
https://doaj.org/article/55f00a22f62d40f292788955aec4af09

المؤلفون: Mariam Fayyaz, Muhammad Numair Younis, Sheikh Danial Hanan, Syed Zain Ul Abidin, Rimsha Badar, Muhammad Waseem Akram

المصدر: Asian Journal of Medical Sciences, Vol 13, Iss 11, Pp 59-63 (2022)

مصطلحات موضوعية: 18 f-fluorodeoxyglucose positron emission tomography/computed tomography, computed tomography negative, positron emission tomography positive, skeletal metastasis, Medicine

وصف الملف: electronic resource

Relation: https://www.nepjol.info/index.php/AJMS/article/view/45979; https://doaj.org/toc/2467-9100; https://doaj.org/toc/2091-0576

URL الوصول: https://doaj.org/article/4b3a5c6dd41646c6bbea8bd9d67bc99a

المؤلفون: Chen, K., Hou, L., Chen, M., Li, S., Shi, Y., Raynor, W.Y., Yang, H.

المساهمون: Department of Radiation Oncology, University of Arizona

المصدر: Life

مصطلحات موضوعية: 18 F-fluorodeoxyglucose positron emission tomography/computed tomography, epidermal growth factor receptor, lung cancer, radiogenomics, stereotactic body radiation therapy

Relation: Chen, K.; Hou, L.; Chen, M.; Li, S.; Shi, Y.; Raynor, W.Y.; Yang, H. Predicting the Efficacy of SBRT for Lung Cancer with 18F-FDG PET/CT Radiogenomics. Life 2023, 13, 884. https://doi.org/10.3390/life13040884; http://hdl.handle.net/10150/673935; Life

الاتاحة: http://hdl.handle.net/10150/673935
https://doi.org/10.3390/life13040884

المؤلفون: A. Yu. Shurinov, E. V. Borodavina, А. Ю. Шуринов, Е. В. Бородавина

المصدر: Head and Neck Tumors (HNT); Том 13, № 1 (2023); 91-101 ; Опухоли головы и шеи; Том 13, № 1 (2023); 91-101 ; 2411-4634 ; 2222-1468 ; 10.17650/2222-1468-2023-13-1

مصطلحات موضوعية: TENIS-синдром, dynamic observation, differentiated thyroid cancer, 131 I whole-body scintigraphy, 131 I single-photon emission computed tomography/X-ray computed tomography, 18 F-fluorodeoxyglucose positron emission tomography/computed tomography, TENIS syndrome, динамическое наблюдение, дифференцированный рак щитовидной железы, сцинтиграфия всего тела с 131 I, однофотонная эмиссионная компьютерная томография, совмещенная с рентгеновской компьютерной томографией, с 131 I, позитронная эмиссионная томография, совмещенная с компьютерной томографией, с 18 F-фтордезоксиглюкозой

وصف الملف: application/pdf

Relation: https://ogsh.abvpress.ru/jour/article/view/871/575; Filetti S., Durante C., Hartl D., Leboulleux S. et al. Berruti on behalf of the ESMO Guidelines Committee. 2019. Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2019;30(12):1856–83. DOI:10.1093/annonc/mdz400; Клинические рекомендации. Дифференцированный рак щитовидной железы. 2020 г. Доступно по: https://cr.minzdrav.gov.ru/schema/329_1#doc_a1.; Gulec S., Ahuja S., Avram A. et al. A joint statement from the American Thyroid Association, the European Association of Nuclear Medicine, the European Thyroid Association, the Society of Nuclear Medicine and Molecular Imaging on Current Diagnostic and Theranostic Approaches in the Management of Thyroid Cancer. Thyroid 2021;31(7):1009–19. DOI:10.1089/ thy.2020.0826; Haddad R., Bischoff L., Ball D. et al. Thyroid Carcinoma. Version 2.2022. NCCN Clinical Practice Guidelines in Oncology. J Nat Compr Canc Netw 2022;20(8):925–51. DOI:10.6004/ jnccn.2022.0040; Шуринов А.Ю., Крылов В.В., Бородавина Е.В. Радиойодаблация при раке щитовидной железы. Исторические и современные аспекты. Обзор литературы. Онкологический журнал: лучевая диагностика, лучевая терапия 2021;4(4):9–19. DOI:10.37174/2587-7593-2021-4-4-9-19; Duren M., Siperstein A., Shen W. et al. Value of stimulated serum thyroglobulin levels for detecting persistent or recurrent differentiated thyroid cancer in high- and low-risk patients. Surgery 1999;26(1):13–9. DOI:10.1067/msy.1999.98849; Pacini F., Lippi F., Formica N. et al. Therapeutic doses of iodine-131 reveal undiagnosed metastases in thyroid cancer patients with detectable serum thyroglobulin levels. J Nucl Med 1987;28(12):1888–91.; Pineda J., Lee T., Ain K. et al. Iodine-131 therapy for thyroid cancer patients with elevated thyroglobulin and negative diagnostic scan. J Clin Endocrinol Metab 1995;80(5):1488–92. DOI:10.1210/ jcem.80.5.7744991; Roelants V., De Nayer P., Bouckaert A., Beckers C. The predictive value of serum thyroglobulin in the follow-up of differentiated thyroid cancer. Eur J Nucl Med 1997;24:722–7. DOI:10.1007/ BF00879658; Pacini F., Molinaro E., Castagna M. et al. Ablation of thyroid residues with 30 mCi 131I: a comparison in thyroid cancer patients prepared with recombinant human TSH or thyroid hormone withdrawal. J Clin Endocrinol Metab 2002;87(9):4063–8. DOI:10.1210/jc.2001-011918; Kukulska A., Krajewska J., Gawkowska-Suwiriska M. et al. Radioiodine thyroid remnant ablation in patients with differentiated thyroid carcinoma (DTC): prospective comparison of long-term outcomes of treatment with 30, 60, and 100 mCi. Thyroid Res 2010;3(1):9. DOI:10.1186/1756-6614-3-9; Toubeau M., Touzery C., Arveux P. et al. Predictive value for disease progression of serum thyroglobulin levels measured in the postoperative period and after 131I ablation therapy in patients with differentiated thyroid cancer. J Nucl Med 2004;45(6):988–94.; Haugen B., Alexander E., Bible K.C. et al. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid 2016;26(1):1–133. DOI:10.1089/thy.2015.0020; Lamartina L., Grani G., Durante C., Filetti S. Recent advances in managing differentiated thyroid cancer. F1000Res 2018;7:86. DOI:10.12688/f1000research.12811.1; Gray J., Singh G., Uttley L., Balasubramanian S. Routine thyroglobulin, neck ultrasound and physical examination in the routine follow up of patients with differentiated thyroid cancer: where is the evidence? Endocrine 2018;62(1):26–33. DOI:10.1007/s12020-018-1720-3; Prpić M., Franceschi M., Romić M. et al. Thyroglobulin as a tumor marker in differentiated thyroid cancer – clinical considerations. Acta Clin Croat 2018;57(3):518–27. DOI:10.20471/acc.2018.57.03.16; Giovanella L., Clark P., Chiovato L. et al. Thyroglobulin measurement using highly sensitive assays in patients with differentiated thyroid cancer: a clinical position paper. Eur J Endocrinol 2014;171(2):R33–46. DOI:10.1530/EJE-14-0148; Spencer C. Clinical review: clinical utility of thyroglobulin antibody (TgAb) measurements for patients with differentiated thyroid cancers (DTC). J Clin Endocrinol Metab 2011;96(12):3615–27. DOI:10.1210/jc.2011-1740; Dekker B., Van der Horst-Schrivers A., Brouwers A. et al. Clinical irrelevance of lower titer thyroglobulin autoantibodies in patients with differentiated thyroid carcinoma. Eur Thyroid J 2022 20;11(6):e220137. DOI:10.1530/ETJ-22-0137; Brassard M., Borget I., Edet-Sanson A. et al. Long-term follow-up of patients with papillary and follicular thyroid cancer: a prospective study on 715 patients. J Clin Endocrinol Metab 2011;96(5):1352–9. DOI:10.1210/jc.2010-2708; Durante C., Montesano T., Attard M. et al. Long-term surveillance of papillary thyroid cancer patients who do not undergo postoperative radioiodine remnant ablation: is there a role for serum thyroglobulin measurement? J Clin Endocrinol Metab 2012;97(8):2748–53. DOI:10.1210/jc.2012-1123; Angell T., Spencer C., Rubino B. et al. In search of an unstimulated thyroglobulin baseline value in low-risk papillary thyroid carcinoma patients not receiving radioactive iodine ablation. Thyroid 2014;24(7):1127–33. DOI:10.1089/thy.2013.0691; Grani G., Fumarola A. Thyroglobulin in lymph node fine-needle aspiration washout: a systematic review and meta-analysis of diagnostic accuracy. J Clin Endocrinol Metab 2014;99(6):1970–82. DOI:10.1210/jc.2014-1098; Torlontano M., Attard M., Crocetti U. et al. Follow-up of low risk patients with papillary thyroid cancer: role of neck ultrasonography in detecting lymph node metastases. J Clin Endocrinol Metab 2004;89(7):3402–7. DOI:10.1210/ jc.2003-031521; Grani G., Lamartina L., Cantisani V. et al. Enterobserver agreement of various thyroid imaging reporting and data systems. Endocr Connect 2018;7(1):1–7. DOI:10.1530/EC-17-0336; Lamartina L., Grani G., Biffoni M. et al. Risk stratification of neck lesions detected sonographically during the follow-up of differentiated thyroid cancer. J Clin Endocrinol Metab 2016;101(8):3036–44. DOI:10.1210/jc.2016-1440; Leboulleux S., Girard E., Rose M. et al. Ultrasound criteria of malignancy for cervical lymph nodes in patients followed up for differentiated thyroid cancer. J Clin Endocrinol Metab 2007;92(9):3590–4. DOI:10.1210/jc.2007-0444; Leenhardt L., Erdogan M., Hegedus L. et al. 2013 European Thyroid Association guidelines for cervical ultrasound scan and ultrasound-guided techniques in the postoperative management of patients with thyroid cancer. Eur Thyroid J 2013;2(3):147–59. DOI:10.1159/000354537; Lamartina L., Deandreis D., Durante C., Filetti S. ENDOCRINE TUMOURS: imaging in the follow-up of differentiated thyroid cancer: current evidence and future perspectives for a risk-adapted approach. Eur J Endocrinol 2016;175(5):R185–202. DOI:10.1530/ EJE-16-0088; Grani G., Ramundo V., Falcone R. et al. Thyroid cancer patients with no evidence of disease: the need for repeat neck ultrasound. J Clin Endocrinol Metab 2019;104(11):4981–9. DOI:10.1210/jc.2019-00962; Castagna M., Maino F., Cipri C. et al. Delayed risk stratification, to include the response to initial treatment (surgery and radioiodine ablation), has better outcome predictivity in differentiated thyroid cancer patients. Eur J Endocrinol 2011;165(3):441–6. DOI:10.1530/EJE-11-0466; Tuttle R., Tala H., Shah J. et al. Estimating risk of recurrence in differentiated thyroid cancer after total thyroidectomy and radioactive iodine remnant ablation: using response to therapy variables to modify the initial risk estimates predicted by the new American Thyroid Association staging system. Thyroid 2010;20(12):1341–9. DOI:10.1089/thy.2010.0178; Durante C., Attard M., Torlontano M. et al. Identification and optimal postsurgical follow-up of patients with very low-risk papillary thyroid microcarcinomas. J Clin Endocrinol Metab 2010;95(11):4882–8. DOI:10.1210/jc.2010-0762; Tuttle R., Tala H., Shah J. et al. Estimating risk of recurrence in differentiated thyroid cancer after total thyroidectomy and radioactive iodine remnant ablation: using response to therapy variables to modify the initial risk estimates predicted by the new American Thyroid Association staging system. Thyroid 2010; 20(12):1341–9. DOI:10.1089/thy.2010.0178; Jeon M., Kim W., Park W. et al. Modified dynamic risk stratification for predicting recurrence using the response to initial therapy in patients with differentiated thyroid carcinoma. Eur J Endocrinol 2014;170:23–30. DOI:10.1530/EJE-13-0524; Han J., Kim W., Yim J. et al. Long-term clinical outcome of differentiated thyroid cancer patients with undetectable stimulated thyroglobulin level one year after initial treatment. Thyroid 2012;22(8):784–90. DOI:10.1089/thy.2011.0322; Scheffel R., Zanella A., Antunes D. et al. Low recurrence rates in a cohort of differentiated thyroid carcinoma patients: a referral center experience. Thyroid 2015;25(8):883–9. DOI:10.1089/thy.2015.0077; Llamas-Olier A., Cuéllar D., Buitrago G. Intermediate-risk papillary thyroid cancer: risk factors for early recurrence in patients with excellent response to initial therapy. Thyroid 2018;28(10):1311–7. DOI:10.1089/thy.2017.0578; Ganly I., Nixon I., Wang L. et al. Survival from differentiated thyroid cancer: what has age got to do with it? Thyroid 2015;25(10):1106–14. DOI:10.1089/thy.2015.0104; Comtois R., Theriault C., Del Vecchio P. Assessment of the efficacy of iodine-131 for thyroid ablation. J Nucl Med 1993;34(11):1927–30.; Schlumberger M., Berg G., Cohen O. et al. Follow-up of low-risk patients with differentiated thyroid carcinoma. Eur J Endocrinol 2004;150(2):105–12. DOI:10.1530/eje.0.1500105; Sacks W., Fung C., Chang J. et al. The effectiveness of radioactive iodine for treatment of low-risk thyroid cancer: a systematic analysis of the peer-reviewed literature from 1966 to April 2008. Thyroid 2010;20(11):1235–45. DOI:10.1089/thy.2009.0455; Dietlein M., Eschner W., Grünwald F. et al. Procedure guidelines for radioiodine therapy of differentiated thyroid cancer. Nuklearmedizin 2016;55:77–89. DOI:10.1055/s-0037-1616478; Gastanga M., Cantara S., Pacini F. Reappraisal of the indication for radioiodine thyroid ablation in differentiated thyroid cancer patients. J Endocrinol Invest 2016;39(10):1087–94. DOI:10.1007/s40618-016-0503-z; Deandreis D., Rubino C., Tala H. et al. Comparison of empiric versus whole-body-blood clearance dosimetry-based approach to radioactive iodine treatment in patients with metastases from differentiated thyroid cancer. J Nucl Med 2017;58(5):717–22. DOI:10.2967/jnumed.116.179606; Verburg F., Schmidt M., Kreissl M. et al. Procedural guideline for Iodine-131 whole-body scintigraphy in differentiated thyroid carcinoma (version 5). Nuklearmedizin 2019;58(3):228–41. DOI:10.1055/a-0891-1839; Giovanella L., Treglia G., Sadeghi R. et al. Unstimulated highly sensitive thyroglobulin in follow-up of differentiated thyroid cancer patients: a meta-analysis. J Clin Endocrinol Metab 2014;99(2):440– 7. DOI:10.1210/jc.2013-3156; Francis G., Waguespack S., Bauer A. et al. American Thyroid Association Guidelines Task Force Management guidelines for children with thyroid nodules and differentiated thyroid cancer. Thyroid 2015;25(7):716–59. DOI:10.1089/thy.2014.0460; Li J., He Z., Bansal V., Hennessey J. Low iodine diet in differentiated thyroid cancer: a review. Clin Endocrinol (Oxf) 2016;84(1):3–12. DOI:10.1111/cen.12846; Campennì А., Barbaro D., Guzzo M. et al. Personalized management of differentiated thyroid cancer in real life – practical guidance from a multidisciplinary panel of experts. Endocrine 2020;70(2):280–91. DOI:10.1007/s12020-020-02418-x; Feine U., Lietzenmayer R., Hanke J. et al. 18FDG whole-body PET in differentiated thyroid carcinoma. Flipflop in uptake patterns of 18FDG and 131I. [In German]. Nuklearmedizin 1995;34(4):127–34.; Feine U., Lietzenmayer R., Hanke J. et al. Fluorine-18-FDG and iodine-131-iodide uptake in thyroid cancer. J Nucl Med 1996;37(9):1468–72.; Asa S., Aksoy S., Vatankulu B. et al. The role of FDG-PET/CT in differentiated thyroid cancer patients with negative iodine-131 whole-body scan and elevated anti-Tg level. Ann Nucl Med 2014;28(10):970–9. DOI:10.1007/s12149-014-0897-7; Liu Y. The role of 18F-FDG PET/CT in the follow-up of well-differentiated thyroid cancer with negative thyroglobulin but positive and/or elevated antithyroglobulin antibody. Nucl Med Commun 2016;37(6):577–82. DOI:10.1097/MNM.0000000000000480; Ozkan E., Aras G., Kucuk N. Correlation of 18F-FDG PET/CT findings with histopathological results in differentiated thyroid cancer patients who have increased thyroglobulin or antithyroglobulin antibody levels and negative 131I whole-body scan results. Clin Nucl Med 2013;38(5):326–31. DOI:10.1097/RLU.0b013e318286827b; Liu M., Cheng L., Jin Y. et al. Predicting 131I-avidity of metastases from differentiated thyroid cancer using 18F-FDG PET/CT in postoperative patients with elevated thyroglobulin. Sci Rep 2018;8(1):4352. DOI:10.1038/s41598-018-22656-4; Silberstein E. The problem of the patient with thyroglobulin elevation but negative iodine scintigraphy: the TENIS syndrome. Semin Nucl Med 2011;41(2):113–20. DOI:10.1053/j.semnuclmed.2010.10.002; Bartel C., Magerefteh S., Avram A. et al. Snmmi procedure standard for scintigraphy for differentiated thyroid cancer. J Nucl Med Technol 2020;48(3):202–9. DOI:10.2967/jnmt.120.243626; Avram А., Giovanella L., Greenspan B. et al. SNMMI procedure standard/eanm practice guideline for nuclear medicine evaluation and therapy of differentiated thyroid cancer: abbreviated version. J Nucl Med 2022;63(6):15N–35N.; Petranović P., Kreissl M., Campenni A. et al. SNMMI/EANM practice guideline vs. ETA Consensus Statement: differences and similarities in approaching differentiated thyroid cancer management-the EANM perspective. Eur J Nucl Med Mol Imaging 2022;49(12):3959–63. DOI:10.1007/s00259-022-05935-1; Giovanella L., Treglia G., Ceriani L., Verburg F. Detectable thyroglobulin with negative imaging in differentiated thyroid cancer patients. What to do with negative anatomical imaging and radioiodine scan? Nuklearmedizin 2014;53(1):1–10. DOI:10.3413/Nukmed-0618-13-08; Van Nostrand D. Radioiodine imaging for differentiated thyroid cancer: not all radioiodine images are performed equally. Thyroid 2019;29(7):901–9.; Donohoe K., Aloff J., Avram А. et al. Appropriate use criteria for nuclear medicine in the evaluation and treatment of differentiated thyroid cancer. J Nucl Med 2020;61(3):375–96. DOI:10.2967/jnumed.119.240945; Binse I., Poeppel T., Ruhlmann M. et al. 68Ga-DOTATOC PET/CT in patients with iodine- and 18F-FDG-negative differentiated thyroid carcinoma and elevated serum thyroglobulin. J Nucl Med 2016;57(10):1512–7. DOI:10.2967/jnumed.115.171942; Vrachimis A., Stegger L., Wenning C. et al. 68Ga-DOTATATE PET/ MRI and 18F-FDG PET/CT are complementary and superior to diffusion-weighted MR imaging for radioactive-iodine-refractory differentiated thyroid cancer. Eur J Nucl Med Mol Imaging 2016;43(10):1765–72. DOI:10.1007/s00259-016-3378-5; Czepczynski R., Matysiak-Grzes M., Gryczynska M. et al. Peptide receptor radionuclide therapy of differentiated thyroid cancer: efficacy and toxicity. Arch Immunol Ther Exp (Warsz) 2015;63(2):147–54. DOI:10.1007/s00005-014-0318-6; Versari A., Sollini M., Frasoldati A. et al. Differentiated thyroid cancer: A new perspective with radiolabeled somatostatin analogues for imaging and treatment of patients. Thyroid 2014;24(4):715–26. DOI:10.1089/thy.2013.0225; Roll W., Riemann B., Schafers M. et al. 177Lu-DOTATATE therapy in radioiodine-refractory differentiated thyroid cancer: a single center experience. Clin Nucl Med 2018;43(10):e346–51. DOI:10.1097/RLU.0000000000002219; Gubbi S., Koch C., Klubo-Gwiezdzinska J. Peptide receptor radionuclide therapy in thyroid cancer. Front endocrinol (Lausanne) 2022;13:896287. DOI:10.3389/fendo.2022.896287; Ryu Y.J., Lim S.Y., Na Y.M. et al. Prostate-specific membrane antigen expression predicts recurrence of papillary thyroid carcinoma after total thyroidectomy. BMC Cancer 2022;22(1):1278. DOI:10.1186/s12885-022-10375-z; Piek M., De Vries L., Donswijk M. et al. Ploeg IMC. Retrospective analysis of PSMA PET/CT thyroid incidental uptake in adults: incidence, diagnosis, and treatment/outcome in a tertiary cancer referral center and University Medical Center. Eur J Nucl Med Mol Imaging 2022;49(7):2392–400. DOI:10.1007/s00259-022-05679-y; https://ogsh.abvpress.ru/jour/article/view/871

الاتاحة: https://ogsh.abvpress.ru/jour/article/view/871
https://doi.org/10.17650/2222-1468-2023-13-1-91-101

المؤلفون: Fayyaz, Mariam, Muhammad Numair Younis, Sheikh Danial Hanan, Syed Zain Ul Abidin, Rimsha Badar, Muhammad Waseem Akram

المصدر: Asian Journal of Medical Sciences; Vol. 13 No. 11 (2022); 59-63 ; 2091-0576 ; 2467-9100

مصطلحات موضوعية: 18 F-fluorodeoxyglucose positron emission tomography/computed tomography, Computed tomography negative, Positron emission tomography positive, Skeletal metastasis

وصف الملف: application/pdf

Relation: https://nepjol.info/index.php/AJMS/article/view/45979/36509; https://nepjol.info/index.php/AJMS/article/view/45979

الاتاحة: https://nepjol.info/index.php/AJMS/article/view/45979

المؤلفون: Ken Yamagiwa, Junichi Tsuchiya, Kota Yokoyama, Ryosuke Watanabe, Koichiro Kimura, Mitsuhiro Kishino, Ukihide Tateishi

المصدر: Diagnostics; Volume 12; Issue 10; Pages: 2500

مصطلحات موضوعية: image quality, deep learning reconstruction, semiconductor-based PET/CT, 18 F-fluorodeoxyglucose positron emission tomography

وصف الملف: application/pdf

Relation: Machine Learning and Artificial Intelligence in Diagnostics; https://dx.doi.org/10.3390/diagnostics12102500

الاتاحة: https://doi.org/10.3390/diagnostics12102500

المؤلفون: Kumiko Hayashi, Tomoyuki Fujioka, Masatake Hara, Yuichi Kumaki, Goshi Oda, Emi Yamaga, Mio Mori, Iichiroh Ohnishi, Kazunori Kubota, Tsuyoshi Nakagawa

المصدر: Diagnostics; Volume 12; Issue 10; Pages: 2308

مصطلحات موضوعية: 18 F-fluorodeoxyglucose positron-emission tomography, granulocyte colony stimulating factor, breast cancer, bone marrow, chemotherapy

وصف الملف: application/pdf

Relation: Medical Imaging and Theranostics; https://dx.doi.org/10.3390/diagnostics12102308

الاتاحة: https://doi.org/10.3390/diagnostics12102308

المؤلفون: Chengcheng Gong, Cheng Liu, Zhonghua Tao, Jian Zhang, Leiping Wang, Jun Cao, Yannan Zhao, Yizhao Xie, Xichun Hu, Zhongyi Yang, Biyun Wang

المصدر: Cancers; Volume 14; Issue 16; Pages: 3973

مصطلحات موضوعية: metastatic breast cancer, heterogeneity, HER2, 18 F-fluorodeoxyglucose positron emission tomography/computed tomography, pyrotinib, therapy response

وصف الملف: application/pdf

Relation: https://dx.doi.org/10.3390/cancers14163973

الاتاحة: https://doi.org/10.3390/cancers14163973

المؤلفون: T. M. Geliashvili, A. V. Vazhenin, T. P. Berezovskaya, N. G. Afanasyeva, E. V. Vasilyeva, P. I. Garbuzov, V. V. Krylov

المصدر: Опухоли головы и шеи, Vol 9, Iss 4, Pp 10-16 (2020)

مصطلحات موضوعية: 18 f-fluorodeoxyglucose positron emission tomography combined with computed tomography, differentiated thyroid cancer, radioiodine therapy, post-therapeutic 131 i whole-body scintigraphy, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

Relation: https://ogsh.abvpress.ru/jour/article/view/444; https://doaj.org/toc/2222-1468; https://doaj.org/toc/2411-4634

URL الوصول: https://doaj.org/article/7ff77a487da14741b998b71d61c25adc

المؤلفون: Cortés Canteli, Marta, Gispert López, Juan Domingo, Salvadó, Gemma, Toribio Fernández, Raquel, Tristão Pereira, Catarina, Falcón, Carles, Oliva, Belén, Mendiguren, José, Fernández Friera, Letícia, Sanz, Javier, García-Ruiz de Morales, José María, Fernández Ortiz, Antonio, Sánchez González, Javier, Ibáñez, Borja, Molinuevo, José Luis, Fuster, Valentín

مصطلحات موضوعية: (18)F-fluorodeoxyglucose-positron emission tomography, Alzheimer’s disease, Cardiovascular risk, Dementia, Hypertension, Statistical parametric mapping

وصف الملف: application/pdf

Relation: J Am Coll Cardiol. 2021;77(7):888-98; info:eu-repo/grantAgreement/EC/H2020/819775; info:eu-repo/grantAgreement/EC/FP7/115736; info:eu-repo/grantAgreement/EC/H2020/115952; http://hdl.handle.net/10230/48069; http://dx.doi.org/10.1016/j.jacc.2020.12.027

الاتاحة: http://hdl.handle.net/10230/48069
https://doi.org/10.1016/j.jacc.2020.12.027

المؤلفون: Yuuki Sasaki, Noriyuki Kimura, Yasuhiro Aso, Kenichi Yabuuchi, Miki Aikawa, Etsuro Matsubara

المصدر: Biomolecules; Volume 11; Issue 10; Pages: 1496

مصطلحات موضوعية: cerebrospinal fluid, 11 C-Pittsburgh compound B positron emission tomography, 18 F-fluorodeoxyglucose positron emission tomography, matrix metalloproteinases, mild cognitive impairment, tissue inhibitor of metalloproteinases, white matter lesions

جغرافية الموضوع: agris

وصف الملف: application/pdf

Relation: Biological Factors; https://dx.doi.org/10.3390/biom11101496

الاتاحة: https://doi.org/10.3390/biom11101496

المؤلفون: Jeonghyun Kang, Jae-Hoon Lee, Hye Sun Lee, Eun-Suk Cho, Eun Jung Park, Seung Hyuk Baik, Kang Young Lee, Chihyun Park, Yunku Yeu, Jean R. Clemenceau, Sunho Park, Hongming Xu, Changjin Hong, Tae Hyun Hwang

المصدر: Cancers; Volume 13; Issue 3; Pages: 392

مصطلحات موضوعية: colorectal cancer, 18 F-fluorodeoxyglucose positron-emission tomography, prognosis, progression-free survival, radiomics

وصف الملف: application/pdf

Relation: Cancer Biomarkers; https://dx.doi.org/10.3390/cancers13030392

الاتاحة: https://doi.org/10.3390/cancers13030392

المؤلفون: Shinsuke Nirengi, Sayuri Fuse, Shiho Amagasa, Toshiyuki Homma, Ryotaro Kime, Miyuki Kuroiwa, Tasuki Endo, Naoki Sakane, Mami Matsushita, Masayuki Saito, Yuko Kurosawa, Takafumi Hamaoka

المصدر: International Journal of Molecular Sciences; Volume 20; Issue 9; Pages: 2214

مصطلحات موضوعية: 18 F-fluorodeoxyglucose-positron emission tomography, noninvasive, brown adipose tissue (BAT), seasonal temperature fluctuations, cold-induced thermogenesis, thermogenic functional ingredients

جغرافية الموضوع: agris

وصف الملف: application/pdf

Relation: Molecular Endocrinology and Metabolism; https://dx.doi.org/10.3390/ijms20092214

الاتاحة: https://doi.org/10.3390/ijms20092214

المؤلفون: Nevio Taglieri, Cristina Nanni, Gabriele Ghetti, Rachele Bonfiglioli, Francesco Saia, Francesco Buia, Giacomo Maria Lima, Valeria Marco, Antonio Giulio Bruno, Francesco Prati, Stefano Fanti, Claudio Rapezzi

المصدر: Applied Sciences; Volume 9; Issue 4; Pages: 657

مصطلحات موضوعية: cystatin C, 18 F-fluorodeoxyglucose-positron emission tomography, frequency domain-optical coherence tomography, coronary artery calcium score, non-ST-segment elevation acute coronary syndrome

جغرافية الموضوع: agris

وصف الملف: application/pdf

Relation: Optics and Lasers; https://dx.doi.org/10.3390/app9040657

الاتاحة: https://doi.org/10.3390/app9040657

المؤلفون: Follenfant, E., Balamoutoff, N., Lawson-Ayayi, Sylvie, Dutronc, H., Dupon, M., Vital, J. M., Delobel, Pierre, Durox, H., de Clermont-Gallerande, H., Fernandez, P., Dauchy, Frédéric-Antoine

المساهمون: CHU de Bordeaux Pellegrin Bordeaux, Centre de référence IOA complexes du Grand Sud-Ouest Bordeaux (CRIOAC GSO), CHU Bordeaux, Service des Maladies Infectieuses et Tropicales A Bordeaux, CHU Bordeaux-Groupe hospitalier Pellegrin, Institut de Neurosciences cognitives et intégratives d'Aquitaine (INCIA), Université Bordeaux Segalen - Bordeaux 2-Université Sciences et Technologies - Bordeaux 1 (UB)-SFR Bordeaux Neurosciences-Centre National de la Recherche Scientifique (CNRS), Bordeaux population health (BPH), Université de Bordeaux (UB)-Institut de Santé Publique, d'Épidémiologie et de Développement (ISPED)-Institut National de la Santé et de la Recherche Médicale (INSERM), Service Maladies infectieuses et tropicales CHU Toulouse, Pôle Inflammation, infection, immunologie et loco-moteur CHU Toulouse (Pôle I3LM Toulouse), Centre Hospitalier Universitaire de Toulouse (CHU Toulouse)-Centre Hospitalier Universitaire de Toulouse (CHU Toulouse), Service des Maladies infectieuses et tropicales CHU Limoges, CHU Limoges

المصدر: ISSN: 1297-319X ; Joint Bone Spine ; https://hal.science/hal-03209245 ; Joint Bone Spine, 2019, 86 (4), pp.503-508. ⟨10.1016/j.jbspin.2019.01.009⟩.

مصطلحات موضوعية: Implant, Spine infection, [(18)F]fluorodeoxyglucose positron emission tomography/computed tomography, [SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie

Relation: hal-03209245; https://hal.science/hal-03209245; https://hal.science/hal-03209245/document; https://hal.science/hal-03209245/file/S1297319X19300089.pdf; PII: S1297-319X(19)30008-9

الاتاحة: https://hal.science/hal-03209245
https://hal.science/hal-03209245/document
https://hal.science/hal-03209245/file/S1297319X19300089.pdf
https://doi.org/10.1016/j.jbspin.2019.01.009

المؤلفون: Ory, Sophie, Le Jeune, Florence, Haegelen, Claire, Vicente, Siobhan, Philippot, Pierre, Dondaine, Thibaut, Jannin, Pierre, Drapier, Sophie, Drapier, Dominique, Sauleau, Paul, Vérin, Marc, Péron, Julie

المساهمون: Comportement et noyaux gris centraux = Behavior and Basal Ganglia Rennes, Université de Rennes (UR)-Université européenne de Bretagne - European University of Brittany (UEB)-Centre Hospitalier Universitaire de Rennes CHU Rennes = Rennes University Hospital Ponchaillou -Institut des Neurosciences Cliniques de Rennes = Institute of Clinical Neurosciences of Rennes (INCR), Service de Neurologie Rennes = Neurology Rennes, Centre Hospitalier Universitaire de Rennes CHU Rennes = Rennes University Hospital Ponchaillou, CRLCC Eugène Marquis (CRLCC), UNICANCER, Service de neurochirurgie Rennes = Neurosurgery Rennes, Laboratoire Traitement du Signal et de l'Image (LTSI), Université de Rennes (UR)-Institut National de la Santé et de la Recherche Médicale (INSERM), Centre de recherches sur la cognition et l'apprentissage UMR 7295 (CeRCA Poitiers ), Université de Poitiers = University of Poitiers (UP)-Université de Tours (UT)-Centre National de la Recherche Scientifique (CNRS), Groupe interdisciplinaire de Recherche sur la Socialisation, l'Education et la Formation (Girsef), Université Catholique de Louvain = Catholic University of Louvain (UCL), Service de Psychiatrie de l'adulte Rennes, Université de Rennes (UR)-Université européenne de Bretagne - European University of Brittany (UEB)-Centre Hospitalier Guillaume Régnier, Neuroscience of Emotion and Affective Dynamics (NEAD), Université de Genève = University of Geneva (UNIGE), This work was supported by the France Parkinson Non-Profit Organization, Rennes University Hospital (data acquisition), the Swiss National Foundation (grant no. 105314_140622), and NCCR Affective Sciences (project no. 202 – UN7126, Prof. Grandjean JP ).

المصدر: ISSN: 1748-6645.

مصطلحات موضوعية: 18[F]fluorodeoxyglucose positron emission tomography, insula, emotion, feelings, subthalamic nucleus, cerebellum, orbitofrontal cortex, [SDV.IB]Life Sciences [q-bio]/Bioengineering

Relation: info:eu-repo/semantics/altIdentifier/pmid/26670087; hal-01247280; https://hal.science/hal-01247280; https://hal.science/hal-01247280/document; https://hal.science/hal-01247280/file/Pre-frontal-insular-cerebellar%20modifications%20correlate%20with%20disgust_accepted.pdf; PUBMED: 26670087

الاتاحة: https://hal.science/hal-01247280
https://hal.science/hal-01247280/document
https://hal.science/hal-01247280/file/Pre-frontal-insular-cerebellar%20modifications%20correlate%20with%20disgust_accepted.pdf
https://doi.org/10.1111/jnp.12094

المؤلفون: 新田, 良和, Nitta, Yoshikazu

مصطلحات موضوعية: computed tomography angiography, coronary artery disease, (18)F-fluorodeoxyglucose–positron emission tomography, high-sensitivity C-reactive protein, pioglitazone, vascular inflammation

وصف الملف: application/pdf

URL الوصول: https://ndlsearch.ndl.go.jp/books/R100000039-I11239186

Degree: 博士（医学） -- 久留米大学

المؤلفون: Cortes-Canteli, Marta, Gispert, Juan Domingo, Salvadó, Gemma, Toribio-Fernandez, Raquel, Tristão-Pereira, Catarina, Falcon, Carles, Oliva, Belen, Mendiguren, Jose M, Fernandez-Friera, Leticia, Sanz, Javier, Garcia-Ruiz, Jose M, Fernandez-Ortiz, Antonio, Sanchez-Gonzalez, Javier, Ibanez, Borja, Molinuevo, José Luis, Fuster, Valentin

المساهمون: Banco Santander, Instituto de Salud Carlos III - ISCIII, European Regional Development Fund (ERDF/FEDER), Fondo de Investigaciones Sanitarias, Comunidad de Madrid, Fundación La Caixa, Ministerio de Ciencia e Innovación (España), European Research Council, Pro, Horizon 2020, Instituto de Salud Carlos III, Unión Europea. Fondo Europeo de Desarrollo Regional (FEDER/ERDF), Comunidad de Madrid (España), Fundación ProCNIC, Unión Europea. Comisión Europea. H2020, Unión Europea. Fondo Social Europeo (ESF/FSE)

المصدر: Repisalud
Instituto de Salud Carlos III (ISCIII)

مصطلحات موضوعية: Statistical parametric mapping, Hypertension, Dementia, (18)F-fluorodeoxyglucose-positron emission tomography, Cardiovascular risk, Alzheimer’s disease

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::21545ebf6ab4125df1f6676aac895cea
http://hdl.handle.net/20.500.12105/12368

المؤلفون: Sneha Shah, Venkatesh Rangarajan, Nilendu Purandare, Anjali Prakash, Archi Agrawal, Ameya D Puranik

المصدر: Indian Journal of Nuclear Medicine : IJNM : The Official Journal of the Society of Nuclear Medicine, India

مصطلحات موضوعية: musculoskeletal diseases, medicine.medical_specialty, pulmonary artery embolism, tumor embolus, Tumor thrombus, Chondroblastic Osteosarcoma, tumor thrombus, medicine, Radiology, Nuclear Medicine and imaging, cardiovascular diseases, Thrombus, neoplasms, 18 F fluorodeoxyglucose positron emission tomography/computed tomography, medicine.diagnostic_test, business.industry, medicine.disease, inferior vena cava thrombus, Pulmonary embolism, Positron emission tomography, cardiovascular system, chondroblastic osteosarcoma, Osteosarcoma, Fdg pet ct, Interesting Image, Radiology, business, Venous thromboembolism, circulatory and respiratory physiology

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7354e2b510131ccf7e4f0e17635f6f4e
http://europepmc.org/articles/PMC8320837

المؤلفون: Perneczky, Robert, Drzezga, Alexander, Boecker, Henning, Ceballos-Baumann, Andres O., Granert, Oliver, Förstl, Hans, Kurz, Alexander, Häussermann, Peter

مصطلحات موضوعية: info:eu-repo/classification/ddc, 18 F-fluorodeoxyglucose positron emission tomography, Dementia with Lewy bodies, Parkinson’s disease, Cognitive reserve

وصف الملف: application/pdf

Relation: https://mediatum.ub.tum.de/1218499; https://mediatum.ub.tum.de/doc/1218499/document.pdf

الاتاحة: https://mediatum.ub.tum.de/1218499
https://mediatum.ub.tum.de/doc/1218499/document.pdf
https://doi.org/10.1159/000167791